Chemoinformaics analysis of (2E,4E)-2,4-Decadienoic acid
| Molecular Weight | 168.236 | nRot | 6 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 3 |
| Exact Molecular Weight | 168.115 | nRing | 0 |
| Solubility: LogS | -2.453 | nHRing | 0 |
| Solubility: LogP | 2.785 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.9727 |
| nHD | 1 | BPOL | 16.9193 |
| QED | 0.489 |
| Synth | 2.715 |
| Natural Product Likeliness | 2.045 |
| NR-PPAR-gamma | 0.11 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.008 |
| CACO-2 | -4.591 |
| MDCK | 0.0000304 |
| BBB | 0.798 |
| PPB | 0.926409 |
| VDSS | 0.229 |
| FU | 0.0892312 |
| CYP1A2-inh | 0.035 |
| CYP1A2-sub | 0.33 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.223 |
| CYP2c9-inh | 0.022 |
| CYP2c9-sub | 0.969 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.413 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.065 |
| CL | 3.07 |
| T12 | 0.833 |
| hERG | 0.032 |
| Ames | 0.03 |
| ROA | 0.86 |
| SkinSen | 0.957 |
| Carcinogencity | 0.667 |
| EI | 0.983 |
| Respiratory | 0.94 |
| NR-Aromatase | 0.043 |
| Antiviral | No |
| Prediction | 0.941962 |